Basically, a brand-name drug company settles a patent infringement lawsuit by paying cash or transferring something else of ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Generic drugmakers and hospital pharmacists warn that added financial pressure from tariffs could strain the nation's generic drug supplies.

Type erasure in Java generics programming can cause a variety of problems in your code. Fortunately, there are ways to work ...

A new study reveals that generic drugs made in India are linked to a significantly higher number of severe adverse events, ...

Amneal Pharmaceuticals (AMRX) is experiencing significant financial growth by focusing on making generic drugs more affordable and accessible—a ...

Malvern-based Endo has agreed to merge with Mallinckrodt in a cash and stock deal, valuing the combined pharmaceutical ...

The FDA has approved the first generic versions of Johnson & Johnson's big-selling anticoagulant Xarelto, which brought in ...

An analysis by Pharmarack, a market research firm, showed that 226 vildagliptin (anti-diabetic) brands are now available in ...

This dramatic disparity reveals how generics serve as the foundation of sustainable healthcare delivery to millions. Among the leaders in this vital industry stands Medochemie, a pharmaceutical ...

The merger will give the combined entity the financial flexibility to pursue drug licensing deals and broaden its therapeutic ...

Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...